vs

Side-by-side financial comparison of CYTOKINETICS INC (CYTK) and FIRST UNITED CORP (FUNC). Click either name above to swap in a different company.

FIRST UNITED CORP is the larger business by last-quarter revenue ($23.2M vs $17.8M, roughly 1.3× CYTOKINETICS INC). FIRST UNITED CORP runs the higher net margin — 24.9% vs -1030.9%, a 1055.7% gap on every dollar of revenue. On growth, FIRST UNITED CORP posted the faster year-over-year revenue change (11.9% vs 4.9%). FIRST UNITED CORP produced more free cash flow last quarter ($15.4M vs $-148.3M).

Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.

United Breweries Holdings Limited (UBHL), also called UB Group, is the Indian subsidiary of Heineken N.V.. It is headquartered in UB City, Bangalore, Karnataka. Its core business includes beverages and investments in various sectors. The company markets beer under the Kingfisher brand, and owns various other brands of alcoholic beverages. United Breweries is India's largest producer of beer.

CYTK vs FUNC — Head-to-Head

Bigger by revenue
FUNC
FUNC
1.3× larger
FUNC
$23.2M
$17.8M
CYTK
Growing faster (revenue YoY)
FUNC
FUNC
+7.0% gap
FUNC
11.9%
4.9%
CYTK
Higher net margin
FUNC
FUNC
1055.7% more per $
FUNC
24.9%
-1030.9%
CYTK
More free cash flow
FUNC
FUNC
$163.7M more FCF
FUNC
$15.4M
$-148.3M
CYTK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CYTK
CYTK
FUNC
FUNC
Revenue
$17.8M
$23.2M
Net Profit
$-183.0M
$5.8M
Gross Margin
Operating Margin
-1004.6%
32.9%
Net Margin
-1030.9%
24.9%
Revenue YoY
4.9%
11.9%
Net Profit YoY
-22.0%
-6.6%
EPS (diluted)
$-1.51
$0.89

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CYTK
CYTK
FUNC
FUNC
Q4 25
$17.8M
$23.2M
Q3 25
$22.7M
Q2 25
$66.8M
$21.8M
Q1 25
$20.9M
Q4 24
$16.9M
$20.8M
Q3 24
$20.3M
Q2 24
$20.1M
Q1 24
$18.7M
Net Profit
CYTK
CYTK
FUNC
FUNC
Q4 25
$-183.0M
$5.8M
Q3 25
$6.9M
Q2 25
$-134.4M
$6.0M
Q1 25
$5.8M
Q4 24
$-150.0M
$6.2M
Q3 24
$5.8M
Q2 24
$4.9M
Q1 24
$3.7M
Operating Margin
CYTK
CYTK
FUNC
FUNC
Q4 25
-1004.6%
32.9%
Q3 25
40.6%
Q2 25
-167.0%
36.5%
Q1 25
36.8%
Q4 24
-821.4%
39.2%
Q3 24
38.0%
Q2 24
32.5%
Q1 24
26.0%
Net Margin
CYTK
CYTK
FUNC
FUNC
Q4 25
-1030.9%
24.9%
Q3 25
30.6%
Q2 25
-201.2%
27.5%
Q1 25
27.7%
Q4 24
-886.3%
29.8%
Q3 24
28.5%
Q2 24
24.5%
Q1 24
19.8%
EPS (diluted)
CYTK
CYTK
FUNC
FUNC
Q4 25
$-1.51
$0.89
Q3 25
$1.07
Q2 25
$-1.12
$0.92
Q1 25
$0.89
Q4 24
$-1.26
$0.95
Q3 24
$0.89
Q2 24
$0.75
Q1 24
$0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CYTK
CYTK
FUNC
FUNC
Cash + ST InvestmentsLiquidity on hand
$122.5M
$131.6M
Total DebtLower is stronger
$95.9M
Stockholders' EquityBook value
$-659.6M
$203.6M
Total Assets
$1.4B
$2.1B
Debt / EquityLower = less leverage
0.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CYTK
CYTK
FUNC
FUNC
Q4 25
$122.5M
$131.6M
Q3 25
$95.2M
Q2 25
$74.9M
$79.1M
Q1 25
$84.4M
Q4 24
$94.9M
$78.3M
Q3 24
$62.4M
Q2 24
$45.1M
Q1 24
$86.9M
Total Debt
CYTK
CYTK
FUNC
FUNC
Q4 25
$95.9M
Q3 25
$95.9M
Q2 25
$609.7M
$120.9M
Q1 25
$120.9M
Q4 24
$619.5M
$120.9M
Q3 24
$120.9M
Q2 24
$70.9M
Q1 24
$70.9M
Stockholders' Equity
CYTK
CYTK
FUNC
FUNC
Q4 25
$-659.6M
$203.6M
Q3 25
$199.1M
Q2 25
$-368.7M
$191.1M
Q1 25
$183.7M
Q4 24
$-135.4M
$179.3M
Q3 24
$174.0M
Q2 24
$164.2M
Q1 24
$165.5M
Total Assets
CYTK
CYTK
FUNC
FUNC
Q4 25
$1.4B
$2.1B
Q3 25
$2.0B
Q2 25
$1.2B
$2.0B
Q1 25
$2.0B
Q4 24
$1.4B
$2.0B
Q3 24
$1.9B
Q2 24
$1.9B
Q1 24
$1.9B
Debt / Equity
CYTK
CYTK
FUNC
FUNC
Q4 25
0.47×
Q3 25
0.48×
Q2 25
0.63×
Q1 25
0.66×
Q4 24
0.67×
Q3 24
0.70×
Q2 24
0.43×
Q1 24
0.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CYTK
CYTK
FUNC
FUNC
Operating Cash FlowLast quarter
$-142.7M
$19.4M
Free Cash FlowOCF − Capex
$-148.3M
$15.4M
FCF MarginFCF / Revenue
-835.2%
66.3%
Capex IntensityCapex / Revenue
31.8%
17.1%
Cash ConversionOCF / Net Profit
3.35×
TTM Free Cash FlowTrailing 4 quarters
$-438.9M
$22.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CYTK
CYTK
FUNC
FUNC
Q4 25
$-142.7M
$19.4M
Q3 25
$1.5M
Q2 25
$-128.2M
$995.0K
Q1 25
$7.0M
Q4 24
$-65.6M
$22.3M
Q3 24
$2.3M
Q2 24
$7.2M
Q1 24
$3.6M
Free Cash Flow
CYTK
CYTK
FUNC
FUNC
Q4 25
$-148.3M
$15.4M
Q3 25
$168.0K
Q2 25
$-132.4M
$706.0K
Q1 25
$6.4M
Q4 24
$-66.9M
$20.4M
Q3 24
$588.0K
Q2 24
$7.0M
Q1 24
$3.5M
FCF Margin
CYTK
CYTK
FUNC
FUNC
Q4 25
-835.2%
66.3%
Q3 25
0.7%
Q2 25
-198.3%
3.2%
Q1 25
30.5%
Q4 24
-395.0%
98.1%
Q3 24
2.9%
Q2 24
35.1%
Q1 24
18.9%
Capex Intensity
CYTK
CYTK
FUNC
FUNC
Q4 25
31.8%
17.1%
Q3 25
5.9%
Q2 25
6.2%
1.3%
Q1 25
2.8%
Q4 24
7.6%
9.3%
Q3 24
8.4%
Q2 24
0.6%
Q1 24
0.3%
Cash Conversion
CYTK
CYTK
FUNC
FUNC
Q4 25
3.35×
Q3 25
0.22×
Q2 25
0.17×
Q1 25
1.20×
Q4 24
3.60×
Q3 24
0.40×
Q2 24
1.46×
Q1 24
0.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CYTK
CYTK

Other$9.1M51%
Collaboration Revenues$8.7M49%

FUNC
FUNC

Trust Department$9.8M42%
Other$5.6M24%
Debit Card Income$4.1M17%
Service Charges$2.3M10%
Brokerage Commissions$1.4M6%

Related Comparisons